A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice

NS1 DNA vaccination protects against Zika infection through T cell–mediated immunity in immunocompetent mice

(2019) B. Grubor-Bauk et al.   Science Advances

Detection of West Nile Virus Infection in Viral Encephalitis Cases, China

(2018) Lei Cao et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Failure of Japanese Encephalitis Vaccine and Infection in Inducing Neutralizing Antibodies against West Nile Virus, People’s Republic of China

(2018) Fang Tang et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

CD8 T cells protect adult naive mice from JEV-induced morbidity via lytic function

(2017) Nidhi Jain et al.   PLoS Neglected Tropical Diseases

Comparison of the live-attenuated Japanese encephalitis vaccine SA14 -14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo

(2016) Sang-Im Yun et al.   JOURNAL OF GENERAL VIROLOGY

Flavivirus NS1: a multifaceted enigmatic viral protein

(2016) Meghana Rastogi et al.   Virology Journal

Generation of a recombinant West Nile virus stably expressing the Gaussia luciferase for neutralization assay

(2016) Pan-Tao Zhang et al.   VIRUS RESEARCH

Current developments in understanding of West Nile virus central nervous system disease

(2014) Kenneth L. Tyler   CURRENT OPINION IN NEUROLOGY

West Nile encephalitis outbreak in Kerala, India, 2011

(2014) B. Anukumar et al.   JOURNAL OF CLINICAL VIROLOGY

Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2

(2014) Dong Yang et al.   VACCINE

Recovery of a chemically synthesized Japanese encephalitis virus reveals two critical adaptive mutations in NS2B and NS4A

(2013) X.-D. Li et al.   JOURNAL OF GENERAL VIROLOGY

An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody

(2013) N. Petrovsky et al.   JOURNAL OF VIROLOGY

Characterization of Japanese encephalitis virus infection in an immortalized mesencephalic cell line, CSM14.1

(2013) Takashi Kimura et al.   MICROBIOLOGY AND IMMUNOLOGY

Characterization of immune responses induced by inactivated, live attenuated and DNA vaccines against Japanese encephalitis virus in mice

(2013) Jieqiong Li et al.   VACCINE

Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex

(2012) Mario Lobigs et al.   Expert Review of Vaccines

Pathogenesis of Japanese Encephalitis Virus Infection in a Golden Hamster Model and Evaluation of Flavivirus Cross-Protective Immunity

(2011) Angela Bosco-Lauth et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus

(2011) Shi-Hua Li et al.   IMMUNOLOGY LETTERS

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses

(2010) M. Lobigs et al.   JOURNAL OF GENERAL VIROLOGY

Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities

(2010) Yongxin Yu   VACCINE

Exclusion of West Nile Virus Superinfection through RNA Replication

(2009) G. Zou et al.   JOURNAL OF VIROLOGY

Live Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis Virus

(2008) M. Lobigs et al.   JOURNAL OF VIROLOGY

Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus

(2007) Byron E. Martina et al.   VACCINE